butorphanol has been researched along with 9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1,2-alpha)benzimidazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anisimova, VA; Grechko, OIu; Shtareva, DM; Spasov, AA | 1 |
| Anisimova, VA; Grechko, OY; Litvinov, RA; Minkin, VI; Rashchenko, AI; Shtareva, DM; Spasov, AA | 1 |
| Grechko, OY; Litvinov, LA; Rashchenko, AI; Shtareva, DM; Spasov, AA | 1 |
3 other study(ies) available for butorphanol and 9-(2-morpholinoethyl)-2-(4-fluorophenyl)imidazo(1,2-alpha)benzimidazole
| Article | Year |
|---|---|
[Analgesic properties of morpholinoethylimidazobenzimidazole derivative RU-1205].
Topics: Analgesics; Animals; Animals, Outbred Strains; Benzimidazoles; Butorphanol; Male; Mice; Morpholines; Naloxone; Naltrexone; Narcotic Antagonists; Nociception; Pain; Pain Measurement; Rats; Receptors, Opioid, kappa | 2013 |
Study of μ- and δ-Opioid Activities in Agents with Various κ-Receptor Selectivity.
Topics: Analgesics, Opioid; Animals; Benzimidazoles; Butorphanol; Drug Evaluation, Preclinical; Gastrointestinal Motility; Ileum; Male; Morphine; Morpholines; Narcotic Antagonists; Rats; Receptors, Opioid, kappa | 2017 |
STUDYING THE PHYSICAL DEPENDENCE ON AND TOLERANCE TO THE ANTINOCICEPTIVE EFFECT OF RU-1205 SUBSTANCE.
Topics: Analgesics; Analgesics, Opioid; Animals; Animals, Outbred Strains; Benzimidazoles; Butorphanol; Drug Administration Schedule; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Morpholines; Naloxone; Narcotic Antagonists; Receptors, Opioid, mu; Substance Withdrawal Syndrome | 2016 |